Skip to main content
Erschienen in: Immunologic Research 1/2023

21.09.2022 | Brief Report

Novel mutation of SLC37A4 in a glycogen storage disease type Ib patient with neutropenia, horseshoe kidney, and arteriovenous malformation: a case report

verfasst von: Sepideh Ebrahimi Meimand, Gholamreza Azizi, Reza Yazdani, Negin Sanadgol, Nima Rezaei

Erschienen in: Immunologic Research | Ausgabe 1/2023

Einloggen, um Zugang zu erhalten

Abstract

Glycogen storage disease type Ib (GSDIb) is an autosomal recessive disorder caused by mutations of SLC37A4 gene, which encodes glucose 6-phosphate translocase (G6PT). Malfunction of G6PT leads to excessive fat and glycogen in liver, kidney, and intestinal mucosa. The clinical manifestations of GSD1b include hepatomegaly, renomegaly, neutropenia, hypoglycemia, and lactic acidosis. Furthermore, the disorder may result in severe complications in long-term including inflammatory bowel disease (IBD), hepatocellular adenomas (HCA), short stature, and autoimmune disorders, which stem from neutropenia and neutrophil dysfunction. Here, we represent a novel mutation of SLC37A4 in a 5-month girl who has a history of hospitalizations several times due to recurrent infection and her early presentations were failure to thrive and tachypnea. Further investigations revealed mild atrial septal defect, mild arteriovenous malformation from left lung, esophageal reflux, Horseshoe kidney, and urinary reflux in this patient. Moreover, the lab tests showed neutropenia, immunoglobulin (Ig) G and IgA deficiency, as well as thrombocytosis. Whole exome sequencing revealed c.1245G > A P.W415 homozygous mutation in SLC37A4 gene and c.580G > A p.V1941 heterozygous mutation in PIK3CD gene. This study shows that manifestations of GSD1b may not be limited to what was previously known and it should be considered in a wider range of patients.
Literatur
1.
Zurück zum Zitat Irons M, Elias ER. Glycogen Storage Diseases. In: Berul CI, Towbin JA, editors. Molecular genetics of cardiac electrophysiology. US Boston, MA: Springer; 2000. p. 219–37.CrossRef Irons M, Elias ER. Glycogen Storage Diseases. In: Berul CI, Towbin JA, editors. Molecular genetics of cardiac electrophysiology. US Boston, MA: Springer; 2000. p. 219–37.CrossRef
2.
Zurück zum Zitat Narisawa K, Igarashi Y, Otomo H, Tada K. A new variant of glycogen storage disease Type I probably due to a defect in the glucose-6-phosphate transport system. Biochem Biophys Res Commun. 1978;83(4):1360–4.CrossRef Narisawa K, Igarashi Y, Otomo H, Tada K. A new variant of glycogen storage disease Type I probably due to a defect in the glucose-6-phosphate transport system. Biochem Biophys Res Commun. 1978;83(4):1360–4.CrossRef
3.
Zurück zum Zitat Pan C-J, Chen S-Y, Lee S, Chou JY. Structure-function study of the glucose-6-phosphate transporter, an eukaryotic antiporter deficient in glycogen storage disease type Ib. Mol Genet Metab. 2009;96(1):32–7.CrossRef Pan C-J, Chen S-Y, Lee S, Chou JY. Structure-function study of the glucose-6-phosphate transporter, an eukaryotic antiporter deficient in glycogen storage disease type Ib. Mol Genet Metab. 2009;96(1):32–7.CrossRef
4.
Zurück zum Zitat Kishnani PS, Koeberl D, Chen Y-T. Glycogen Storage Diseases. In: Scriver CR, Beaudet AL, Sly WS et al., eds. Metabolic and molecular bases of inherited disease. 8th ed. New York: McGraw-Hill, 2009. Kishnani PS, Koeberl D, Chen Y-T. Glycogen Storage Diseases. In: Scriver CR, Beaudet AL, Sly WS et al., eds. Metabolic and molecular bases of inherited disease. 8th ed. New York: McGraw-Hill, 2009.
5.
Zurück zum Zitat Chou JY, Jun HS, Mansfield BC. Neutropenia in type Ib glycogen storage disease. Curr Opin Hematol. 2010;17(1):36–42.CrossRef Chou JY, Jun HS, Mansfield BC. Neutropenia in type Ib glycogen storage disease. Curr Opin Hematol. 2010;17(1):36–42.CrossRef
6.
Zurück zum Zitat Veiga-da-Cunha M, Chevalier N, Stephenne X, Defour J-P, Paczia N, Ferster A, et al. Failure to eliminate a phosphorylated glucose analog leads to neutropenia in patients with G6PT and G6PC3 deficiency. Proc Natl Acad Sci. 2019;116(4):1241–50.CrossRef Veiga-da-Cunha M, Chevalier N, Stephenne X, Defour J-P, Paczia N, Ferster A, et al. Failure to eliminate a phosphorylated glucose analog leads to neutropenia in patients with G6PT and G6PC3 deficiency. Proc Natl Acad Sci. 2019;116(4):1241–50.CrossRef
7.
Zurück zum Zitat Jun HS, Weinstein DA, Lee YM, Mansfield BC, Chou JY. Molecular mechanisms of neutrophil dysfunction in glycogen storage disease type Ib. Blood. 2014;123(18):2843–53.CrossRef Jun HS, Weinstein DA, Lee YM, Mansfield BC, Chou JY. Molecular mechanisms of neutrophil dysfunction in glycogen storage disease type Ib. Blood. 2014;123(18):2843–53.CrossRef
8.
Zurück zum Zitat Rossi A, Simeoli C, Salerno M, Ferrigno R, Della Casa R, Colao A, et al. Imbalanced cortisol concentrations in glycogen storage disease type I: evidence for a possible link between endocrine regulation and metabolic derangement. Orphanet J Rare Dis. 2020;15(1):99.CrossRef Rossi A, Simeoli C, Salerno M, Ferrigno R, Della Casa R, Colao A, et al. Imbalanced cortisol concentrations in glycogen storage disease type I: evidence for a possible link between endocrine regulation and metabolic derangement. Orphanet J Rare Dis. 2020;15(1):99.CrossRef
9.
Zurück zum Zitat Visser G, Rake JP, Fernandes J, Labrune P, Leonard JV, Moses S, et al. Neutropenia, neutrophil dysfunction, and inflammatory bowel disease in glycogen storage disease type Ib: results of the European Study on Glycogen Storage Disease type I. J Pediatr. 2000;137(2):187–91.CrossRef Visser G, Rake JP, Fernandes J, Labrune P, Leonard JV, Moses S, et al. Neutropenia, neutrophil dysfunction, and inflammatory bowel disease in glycogen storage disease type Ib: results of the European Study on Glycogen Storage Disease type I. J Pediatr. 2000;137(2):187–91.CrossRef
10.
Zurück zum Zitat Kishnani PS. Glycogen storage diseases. In: Aminoff MJ, Daroff RB, editors. Encyclopedia of the Neurological Sciences. 2nd ed. Oxford: Academic Press; 2014. p. 454–9.CrossRef Kishnani PS. Glycogen storage diseases. In: Aminoff MJ, Daroff RB, editors. Encyclopedia of the Neurological Sciences. 2nd ed. Oxford: Academic Press; 2014. p. 454–9.CrossRef
11.
Zurück zum Zitat Dror Y, et al. Chapter 29 - Inherited bone marrow failure syndromes. In: Hoffman R, Benz EJ, Silberstein LE, Heslop HE, Weitz JI, Anastasi J, et al., editors. Hematology (Seventh Edition). Elsevier; 2018. p. 350–93. Dror Y, et al. Chapter 29 - Inherited bone marrow failure syndromes. In: Hoffman R, Benz EJ, Silberstein LE, Heslop HE, Weitz JI, Anastasi J, et al., editors. Hematology (Seventh Edition). Elsevier; 2018. p. 350–93.
12.
Zurück zum Zitat Wortmann SB, Van Hove JLK, Derks TGJ, Chevalier N, Knight V, Koller A, et al. Treating neutropenia and neutrophil dysfunction in glycogen storage disease type Ib with an SGLT2 inhibitor. Blood. 2020;136(9):1033–43.CrossRef Wortmann SB, Van Hove JLK, Derks TGJ, Chevalier N, Knight V, Koller A, et al. Treating neutropenia and neutrophil dysfunction in glycogen storage disease type Ib with an SGLT2 inhibitor. Blood. 2020;136(9):1033–43.CrossRef
13.
Zurück zum Zitat Rossi A, Miele E, Fecarotta S, Veiga-da-Cunha M, Martinelli M, Mollica C, et al. Crohn disease-like enterocolitis remission after empagliflozin treatment in a child with glycogen storage disease type Ib: a case report. Ital J Pediatr. 2021;47(1):149.CrossRef Rossi A, Miele E, Fecarotta S, Veiga-da-Cunha M, Martinelli M, Mollica C, et al. Crohn disease-like enterocolitis remission after empagliflozin treatment in a child with glycogen storage disease type Ib: a case report. Ital J Pediatr. 2021;47(1):149.CrossRef
14.
Zurück zum Zitat Bellinati-Pires R, Carneiro-Sampaio MM, Colletto GM. Functional evaluation of human neutrophils. Is the bactericidal activity correlated with nitroblue tetrazolium reduction? J Investig Allergol Clin Immunol. 1992;2(3):146–53. Bellinati-Pires R, Carneiro-Sampaio MM, Colletto GM. Functional evaluation of human neutrophils. Is the bactericidal activity correlated with nitroblue tetrazolium reduction? J Investig Allergol Clin Immunol. 1992;2(3):146–53.
15.
Zurück zum Zitat Lowe C, Doray B, Sokal J, Sarcione E. Carbohydrate metabolism in glycogen storage disease and the mode of action of insulin. Mod Probl Paediat. 1959;4:157. Lowe C, Doray B, Sokal J, Sarcione E. Carbohydrate metabolism in glycogen storage disease and the mode of action of insulin. Mod Probl Paediat. 1959;4:157.
16.
Zurück zum Zitat Cohn A, Ohri A. Diabetes mellitus in a patient with glycogen storage disease type Ia: a case report. J Med Case Rep. 2017;11(1):319.CrossRef Cohn A, Ohri A. Diabetes mellitus in a patient with glycogen storage disease type Ia: a case report. J Med Case Rep. 2017;11(1):319.CrossRef
17.
Zurück zum Zitat Saneifard H, Shamsian B, Shakiba M, Karizi Zarea S, Sheikhy A. A rare case of glycogen storage disease type 1a presenting with hemophagocytic lymphohistiocytosis (HLH). Case Reports Pediatr. 2020;2020:8818617.CrossRef Saneifard H, Shamsian B, Shakiba M, Karizi Zarea S, Sheikhy A. A rare case of glycogen storage disease type 1a presenting with hemophagocytic lymphohistiocytosis (HLH). Case Reports Pediatr. 2020;2020:8818617.CrossRef
18.
Zurück zum Zitat Aguilar-García JJ, Domínguez-Pérez AD, Nacarino-Mejías V, Ruiz-Guerrero CI, Iribarren-Marín MA, Ortega-Seda CJ. Arterial hypertension induced by pyeloureteral stenosis in horseshoe kidney. Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia. 2011;31(3):365–6. Aguilar-García JJ, Domínguez-Pérez AD, Nacarino-Mejías V, Ruiz-Guerrero CI, Iribarren-Marín MA, Ortega-Seda CJ. Arterial hypertension induced by pyeloureteral stenosis in horseshoe kidney. Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia. 2011;31(3):365–6.
19.
Zurück zum Zitat Saboo SS, Chamarthy M, Bhalla S, Park H, Sutphin P, Kay F, et al. Pulmonary arteriovenous malformations: diagnosis. Cardiovasc Diagn Ther. 2018;8(3):325–37.CrossRef Saboo SS, Chamarthy M, Bhalla S, Park H, Sutphin P, Kay F, et al. Pulmonary arteriovenous malformations: diagnosis. Cardiovasc Diagn Ther. 2018;8(3):325–37.CrossRef
20.
Zurück zum Zitat Torok RD, Austin SL, Britt LK, Abdenur JE, Kishnani PS, Wechsler SB. Pulmonary rrterial hypertension in glycogen storage disease type I. J. Inborn Errors Metab Screen. 2017:e160060-e160060. Torok RD, Austin SL, Britt LK, Abdenur JE, Kishnani PS, Wechsler SB. Pulmonary rrterial hypertension in glycogen storage disease type I. J. Inborn Errors Metab Screen. 2017:e160060-e160060.
21.
Zurück zum Zitat Mandola AB, Dadi H, Reid B, Roifman CM. Novel heterozygous PIK3CD mutation presenting with only laboratory markers of combined immunodeficiency. LymphoSign J. 2020;7(2):49–55.CrossRef Mandola AB, Dadi H, Reid B, Roifman CM. Novel heterozygous PIK3CD mutation presenting with only laboratory markers of combined immunodeficiency. LymphoSign J. 2020;7(2):49–55.CrossRef
22.
Zurück zum Zitat Jamee M, Moniri S, Zaki-Dizaji M, Olbrich P, Yazdani R, Jadidi-Niaragh F, et al. Clinical, immunological, and genetic features in patients with activated PI3Kδ syndrome (APDS): a systematic review. Clin Rev Allergy Immunol. 2020;59(3):323–33.CrossRef Jamee M, Moniri S, Zaki-Dizaji M, Olbrich P, Yazdani R, Jadidi-Niaragh F, et al. Clinical, immunological, and genetic features in patients with activated PI3Kδ syndrome (APDS): a systematic review. Clin Rev Allergy Immunol. 2020;59(3):323–33.CrossRef
23.
Zurück zum Zitat Cohen SB, Bainter W, Johnson JL, Lin T-Y, Wong JCY, Wallace JG, et al. Human primary immunodeficiency caused by expression of a kinase-dead p110δ mutant. J Allergy Clin Immunol. 2019;143(2):797-9.e2.CrossRef Cohen SB, Bainter W, Johnson JL, Lin T-Y, Wong JCY, Wallace JG, et al. Human primary immunodeficiency caused by expression of a kinase-dead p110δ mutant. J Allergy Clin Immunol. 2019;143(2):797-9.e2.CrossRef
24.
Zurück zum Zitat Calderwood S, Kilpatrick L, Douglas SD, Freedman M, Smith-Whitley K, Rolland M, et al. Recombinant human granulocyte colony-stimulating factor therapy for patients with neutropenia and/or neutrophil dysfunction secondary to glycogen storage disease type 1b. Blood. 2001;97(2):376–82.CrossRef Calderwood S, Kilpatrick L, Douglas SD, Freedman M, Smith-Whitley K, Rolland M, et al. Recombinant human granulocyte colony-stimulating factor therapy for patients with neutropenia and/or neutrophil dysfunction secondary to glycogen storage disease type 1b. Blood. 2001;97(2):376–82.CrossRef
25.
Zurück zum Zitat Lachaux A, Boillot O, Stamm D, Canterino I, Dumontet C, Regnier F, et al. Treatment with lenograstim (glycosylated recombinant human granulocyte colony-stimulating factor) and orthotopic liver transplantation for glycogen storage disease type Ib. J Pediatr. 1993;123(6):1005–8.CrossRef Lachaux A, Boillot O, Stamm D, Canterino I, Dumontet C, Regnier F, et al. Treatment with lenograstim (glycosylated recombinant human granulocyte colony-stimulating factor) and orthotopic liver transplantation for glycogen storage disease type Ib. J Pediatr. 1993;123(6):1005–8.CrossRef
Metadaten
Titel
Novel mutation of SLC37A4 in a glycogen storage disease type Ib patient with neutropenia, horseshoe kidney, and arteriovenous malformation: a case report
verfasst von
Sepideh Ebrahimi Meimand
Gholamreza Azizi
Reza Yazdani
Negin Sanadgol
Nima Rezaei
Publikationsdatum
21.09.2022
Verlag
Springer US
Erschienen in
Immunologic Research / Ausgabe 1/2023
Print ISSN: 0257-277X
Elektronische ISSN: 1559-0755
DOI
https://doi.org/10.1007/s12026-022-09320-w

Weitere Artikel der Ausgabe 1/2023

Immunologic Research 1/2023 Zur Ausgabe

Update HNO

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.